Natural history of dysplasia of the uterine cervix

Journal of the National Cancer Institute

Volumn 91, Issue 3, 1999, Pages 252-258

  Holowaty, Philippa ^a   Miller, Anthony B ^b   Rohan, Tom ^b   To, Teresa ^b  

^a Durham Region Health Department   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; COHORT ANALYSIS; CYTOPATHOLOGY; DATA BASE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

EID: 0033518607     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.3.252     Document Type: Article

References (36)

1. Chanen W. The ClN saga - the biological and clinical significance of cervical intrepithelial neoplasia. Aust N Z Obstet Gyneacol 1990;30: 18-23.
2. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
3. Boyes DA, Morrison B, Knox EG, Draper GJ, Miller AB. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 1982;5:1-29.
4. Narod SA, Thompson MJ, Wall C, Green LM, Miller AB. Dysplasia and the natural history of cervical cancer: early results of the Toronto Cohort Study. Eur J Cancer 1991;27:1411-6.
5. Task force on cervical cancer screening programs. Conclusions and recommendations of the task force. Can Med Assoc J 1976;114: 1003-33.
6. Cervical cancer screening programs 1982. Ottawa: Health Services and Promotion Branch, Department of National Health and Welfare; 1982. p. 31.
7. Riotton G, Christopherson WM. Cytology of the female genital tract. In: World Health Organization, editor. International histological classification of tumors. Geneva (Switzerland): World Health Organization; 1973.
8. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnosis. JAMA 1989;262: 931-4.
9. Howe GR, Lindsay J. A generalized iterative record linkage computer system for use in medical follow-up studies. Comput Biomed Res 1981;14:327-40.
10. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261:737-43.
11. Richart RM. The patient with an abnormal Pap smear - screening techniques and management. N Engl J Med 1980;302:332-4.
12. Fleiss TL. Statistical methods for rates and proportions. New York (NY): John Wiley & Sons, 1981.
13. Cox DR, Oakes D. Analysis of survival data. Monographs on statistics and applied probability. London (U.K.): Chapman & Hall; 1984. p. 201.
14. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames (IA): Iowa State University Press; 1980.
15. Holowaty PH. The Natural history of cervical dysplasia. Ph.D. thesis. University of Toronto: 1996.
16. Miller AB, Anderson G, Brisson J, Laidlaw J, Le Pitre N, Malcolmson P, et al. Report of a National Workshop on Screening for Cancer of the Cervix. CMAJ 1991;145:1301-25.
17. Galvin GA, Jones HW, Te Linde RW. The significance of basal-cell hyperactivity in cervical biopsies. Am J Obstet Gynecol 1955;70: 808-21.
18. Luthra UK, Prabhakar AK, Seth P, Agarwal SS, Murthy NS, Bhatnagar P, et al. Natural history of precancerous and early cancerous lesions of the uterine cervix. Acta Cytol 1987; 31:226-34.
19. Jones MH, Jenkins D, Cuzick J, Wolfendale MR, Jones JJ, Balogun-Lynch C, et al. Mild cervical dyskaryosis: safety of cytological surveillance. Lancet 1992;339:1440-3.
20. Flannelly G, Anderson D, Kitchener HC, Mann EM, Campbell M, Walker F, et al. Management of women with mild and moderate cervical dyskariosis. BMJ 1994;308:1399-403.
21. Brown MS, Phillips GL Jr. Management of the mildly abnormal Pap smear: a conservative approach. Gynecol Oncol 1985;22:149-53.
22. Robertson JH, Woodend BE, Crozier EH, Hutchinson J. Risk of cervical cancer associated with mild dyskaryosis. BMJ 1988;297: 18-21.
23. Mikhail MS, Merkatz IR, Romney SL. Clinical usefulness of computerized colposcopy: image analysis and conservative management of mild dysplasia. Obstet Gynecol 1992;80: 5-8.
24. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstet Gynecol 1992;79(5 Pt 1):675-82.
25. Campion MJ, Singer A, Mitchell HS. Complacency in diagnosis of cervical cancer. Br Med J 1987;294:1337-9.
26. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9.
27. Carmichael JA, Maskens PD. Cervical dysplasia and human papillomavirus. Am J Obstet Gynecol 1989;160:916-8.
28. Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983;61: 609-14.
29. Murthy NS, Sardana S, Narang N, Agarwal SS, Sharma S, Das DK. Biological behaviour of moderate dysplasia - a prospective study. Indian J Cancer 1996;33:24-30.
30. Giles JA, Hudson E, Crow J, Williams D, Walker P. Colposcopic assessment of the accuracy of cervical cytology screening. Br Med J 1988;296:1099-102.
31. Bos AB, van Ballegooijen M, van Oortmarssen GJ, van Marie ME, Habbema JD, Lynge E. Non-progression of cervical intraepithelial neoplasia estimated from population-screening data. Br J Cancer 1997;75: 124-30.
32. Kirby AJ, Spiegelhalter DJ, Day NE, Fenton L, Swanson K, Mann EM, et al. Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet 1992;339: 828-31.
33. Montz FJ, Monk BJ, Fowler JM, Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992;80(3 Pt 1):385-8.
34. Stern E, Neely PM. Dysplasia of the uterine cervix: Incidence of regression, recurrence, and cancer. Cancer 1964;17:508-12.
35. Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, et al. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989;130:486-96.
36. Hulka BS. Cytologic and histologic outcome following an atypical cervical smear. Am J Obstet Gynecol 1968;101:190-9.